CHFA's Position on Cannabis

CHFA's Position on Cannabis

Access to recreational cannabis should not be more liberal than access to cannabidiol (CBD) containing cannabis products that can improve the health of Canadians.

We believe that the decision to place CBD on the prescription drug list has introduced unintended consequences for Canadians seeking benefits from CBD, as well as the natural health industry interested in providing Canadians with products that support their health. The present regulatory regime for CBD products is stifling innovation, economic development and job creation in our sector while failing to dispel the illicit online market for CBD health products.

CBD is a natural substance that Canadians want access to for health and wellness purposes. Canadians want the same direct access to CBD health products as they have for recreational products. CBD is safe, has no known harmful side effects, is not addictive, and has no intoxicating effects like its well-known counterpart THC.

Since the legalization of cannabis, CHFA has advocated for Health Canada to create a pathway for CBD to be legally sold in natural health products (NHPs). We believe CBD is a NHP, not a recreational drug, and NHP businesses should have the opportunity to provide Canadians with safe and regulated CBD-containing health products, brought to market through the Natural Health Products Regulations.

Health Canada's Consultation

On June 19, Health Canada launched a consultation on a potential regulatory pathway that would bring cannabis health products (or “CHPs”), including CBD health products, to the Canadian marketplace. This proposal would not allow CBD to be included in NHPs, and would not allow health food stores to sell CBD.

In October 2019 CHFA’s President, Helen Long visited Parliament Hill in Ottawa to release our submission to Health Canada’s consultation on cannabis health products. Click here to view the media release.

CBD is Natural

Do you support better access to CBD in NHPs? Learn more at